4.45
-0.12(-2.63%)
Currency In USD
| Previous Close | 4.57 |
| Open | 4.49 |
| Day High | 4.58 |
| Day Low | 4.29 |
| 52-Week High | 14.44 |
| 52-Week Low | 2.86 |
| Volume | 1.86M |
| Average Volume | 2.28M |
| Market Cap | 397.6M |
| PE | -8.24 |
| EPS | -0.54 |
| Moving Average 50 Days | 7.2 |
| Moving Average 200 Days | 8.76 |
| Change | -0.12 |
If you invested $1000 in Anavex Life Sciences Corp. (AVXL) 10 years ago, it would be worth $703 as of December 04, 2025 at a share price of $4.45. Whereas If you bought $1000 worth of Anavex Life Sciences Corp. (AVXL) shares 5 years ago, it would be worth $913.76 as of December 04, 2025 at a share price of $4.45.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
GlobeNewswire Inc.
Nov 26, 2025 12:30 PM GMT
One Oral Late Breaking Communication and Two Poster PresentationsNEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing inn
Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference
GlobeNewswire Inc.
Nov 19, 2025 12:30 PM GMT
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease,
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025
GlobeNewswire Inc.
Nov 18, 2025 12:30 PM GMT
Webcast and Conference Call To be Held Tuesday, November 25, 2025, 8:30 am ETNEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on de